Financhill
Back

Insmed 10K Form

Buy
69

INSM
Insmed

Last Price:
63.93
Seasonality Move:
-5.03%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

Receive INSM News And Ratings

See the #1 stock for the next 7 days that we like better than INSM

INSM Financial Statistics

Sales & Book Value

Annual Sales: $305.21M
Cash Flow: $-188.71M
Price / Cash Flow: 0
Annual Sales: $-3.13
Price / Book: 0

Profitability

EPS (TTM): -5.23000
Net Income (TTM): $-746.89M
Gross Margin: $239.64M
Return on Equity: 0%
Return on Assets: -55.16%

Insmed Earnings Forecast

Key Insmed Financial Ratios

  • The Gross Profit Margin over the past 25 years for INSM is 78.52%.
  • The Selling, General & Administrative Expenses for INSM have been equal to 112.87% of Gross Profit Margin.
  • The Research & Development expenses have been 187.09% of Revenue.
  • The Interest Expense is -10.17% of Operating Income.
  • The Net Earning history of INSM is -245.59% of Total Revenues.
  • Per Share Earnings over the last 25 years have been positive in 9 years.

Insmed Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: INSM
CUSIP: 457669
Website: insmed.com

Debt

Debt-to-Equity Ratio: -2.5
Current Ratio: 1.8
Quick Ratio: 1.5

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

INSM Technical Analysis vs Fundamental Analysis

Buy
69
Insmed (INSM) is a Buy

Is Insmed a Buy or a Sell?

  • Insmed stock is rated a Buy
    The current Insmed [INSM] share price is $63.92. The Score for INSM is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.